PMID: 8588062Jul 1, 1995Paper

Stressful life events and coping styles in relation to dysthymia and major depressive disorder: variations associated with alleviation of symptoms following pharmacotherapy

Progress in Neuro-psychopharmacology & Biological Psychiatry
Arun V RavindranHymie Anisman

Abstract

1. Both major depression and dysthymia (chronic, low grade depression) were associated with increased reports of minor stressors (daily hassles), and feelings of loneliness, reduced uplifts, as well as the use of inappropriate coping strategies (i.e., emotion-focussed rather than problem-oriented coping). 2. Although major depressive and dysthymic patients shared several features with respect to symptomatology, dysthymics tended to report a greater number of hassles than major depressives. 3. Treatment with serotonin reuptake inhibitors over an 8-week period resulted in a marked alleviation of the depressive symptoms in both patient groups, although the clinical effectiveness of the drugs appeared somewhat later in dysthymics. 4. The attenuation of the depressive symptoms was accompanied by a modest, but significant diminution in reports of minor stressors, while the perception of uplifts remained unchanged. Moreover, recovery from depression was associated with changes in coping style, such that patients relied less on inappropriate emotion-focussed coping strategies.

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Oct 1, 1992·Journal of Consulting and Clinical Psychology·S M MonroeE Frank
Aug 1, 1992·The Journal of Nervous and Mental Disease·M E McNaughtonI Grant
Jan 1, 1992·Progress in Neuro-psychopharmacology & Biological Psychiatry·J RosenthalA Winston
Nov 1, 1991·Journal of Abnormal Psychology·C Hammen
Aug 1, 1991·Journal of Consulting and Clinical Psychology·S M MonroeM E Thase
Feb 1, 1991·Journal of Consulting and Clinical Psychology·S D HollonP T Loosen
Feb 1, 1991·Journal of Abnormal Psychology·C J Holahan, R H Moos
Apr 1, 1991·Journal of Clinical Psychopharmacology·R H Howland
Aug 1, 1990·Journal of Abnormal Psychology·J R DuraJ K Kiecolt-Glaser
Dec 1, 1989·Family Practice·S Lydeard, R Jones
Mar 1, 1988·Archives of General Psychiatry·J H KocsisJ Sweeney
Mar 1, 1988·Psychological Bulletin·S E Taylor, J D Brown
Jul 1, 1988·The American Journal of Psychiatry·M M WeissmanL Florio
Jun 1, 1986·Archives of General Psychiatry·G ParkerI Blignault
May 1, 1986·Journal of Abnormal Psychology·C HammenT Marks
Oct 1, 1971·Archives of General Psychiatry·E S PaykelE H Uhlenhuth
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
Jan 1, 1983·The American Journal of Psychiatry·H S Akiskal
Aug 1, 1983·Journal of Consulting and Clinical Psychology·S M MonroeJ M Himmelhoch
Jan 1, 1984·Behaviour Research and Therapy·E E Beckham, R L Adams
Dec 1, 1982·Archives of General Psychiatry·G B Parker, L B Brown
Mar 1, 1981·Archives of General Psychiatry·I GrantM Gerst
Mar 1, 1981·Journal of Behavioral Medicine·A D KannerR S Lazarus
Aug 1, 1994·The American Journal of Psychiatry·J C Markowitz
Aug 1, 1993·The American Journal of Psychiatry·D J HellersteinA Winston
May 1, 1993·Psychosomatic Medicine·R S Lazarus
Jan 1, 1959·The British Journal of Medical Psychology·M HAMILTON
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH

❮ Previous
Next ❯

Citations

Nov 1, 1996·Psychoneuroendocrinology·A V RavindranH Anisman
Jun 7, 2000·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·O AgidB Lerer
Oct 20, 2011·Psychological Medicine·C TelfordG Rowse
Jun 6, 2003·Journal of Abnormal Psychology·Frenk PeetersMarten deVries
Dec 24, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Brian BinghamRita Valentino
May 2, 2002·The Australian and New Zealand Journal of Psychiatry·Christopher Tennant
Oct 11, 2005·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Maj Vinberg Christensen, Lars Vedel Kessing
Sep 9, 1996·Journal of Affective Disorders·A V RavindranH Anisman
Feb 15, 2001·Journal of Affective Disorders·H S Akiskal
Jul 16, 2002·Journal of Affective Disorders·Lawrence P RisoMichael E Thase
Aug 9, 2002·Journal of Affective Disorders·Arun V RavindranHymie Anisman
May 8, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·D P DevanandHarold A Sackeim
Oct 22, 2005·The British Journal of Social Psychology·Kimberly MathesonHymie Anisman
May 17, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Angela HeckMarcus Ising
Aug 2, 2003·Biological Psychiatry·Karen E JoyntChristopher M O'Connor
Jul 16, 2014·Neuroscience and Biobehavioral Reviews·Robyn J McQuaidHymie Anisman
Dec 24, 2013·Journal of Psychosomatic Research·Rebecca R KlatzkinSusan Girdler
Mar 3, 2009·Behaviour Research and Therapy·Thorsten BarnhoferJ Mark G Williams
Nov 7, 2007·The Journal of Nervous and Mental Disease·Rob HavermansMarten W Devries
Jul 13, 2000·Molecular Psychiatry·J GriffithsH Anisman
Mar 20, 2010·The Cochrane Database of Systematic Reviews·Ichiro M OmoriToshi A Furukawa
Mar 1, 1996·Journal of Clinical Gastroenterology·E H Friedman
Sep 27, 2007·Current Pain and Headache Reports·Dan Buskila, Hagit Cohen
Jun 1, 2019·Acta Psychiatrica Scandinavica·L Sher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.